Cell Death-Stimulated Cell Proliferation: A Tissue Regeneration Mechanism Usurped by Tumors During Radiotherapy

Seminars in Radiation Oncology

Volumn 23, Issue 4, 2013, Pages 288-295

  Zimmerman, Mary A ^a   Huang, Qian ^a,b   Li, Fang ^a   Liu, Xinjiang ^a   Li, Chuan Yuan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BETA CATENIN; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CASPASE 3; CASPASE 7; LYSOPHOSPHOCHOLINE; PHOSPHORYLCHOLINE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3 PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL PROLIFERATION; CELL TYPE; COLON CANCER; COMPENSATORY CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEAD AND NECK CANCER; HUMAN; IONIZING RADIATION; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SIGNAL TRANSDUCTION; SKIN INJURY; STEM CELL; TISSUE REGENERATION; TUMOR CELL REPOPULATION; UPREGULATION; WNT SIGNALING PATHWAY; WOUND HEALING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASPASES; HUMANS; LIVER REGENERATION; NEOPLASMS; WOUND HEALING;

EID: 84883530026     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2013.05.003     Document Type: Article

References (98)

1. Okada H., Mak T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004, 4(8):592-603.
2. Bergmann A., Steller H. Apoptosis, stem cells, and tissue regeneration. Sci Signal 2010, 3(145):re8.
3. Fan Y., Bergmann A. Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!. Trends Cell Biol 2008, 18(10):467-473.
4. Demaria S., Bhardwaj N., McBride W.H., et al. Combining radiotherapy and immunotherapy: A revived partnership. Int J Radiat Oncol Biol Phys 2005, 63(3):655-666.
5. Golstein P., Kroemer G. Cell death by necrosis: Towards a molecular definition. Trends Biochem Sci 2007, 32(1):37-43.
6. Festjens N., Vanden Berghe T., Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006, 1757(9-10):1371-1387.
7. Baehrecke E.H. How death shapes life during development. Nat Rev Mol Cell Biol 2002, 3(10):779-787.
8. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26(4):239-257.
9. Lamkanfi M., Declercq W., Kalai M., et al. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002, 9(4):358-361.
10. Beyaert R., Van Loo G., Heyninck K., et al. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 2002, 214:225-272.
11. Saelens X., Festjens N., Vande Walle L., et al. Toxic proteins released from mitochondria in cell death. Oncogene 2004, 23(16):2861-2874.
12. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26(9):1324-1337.
13. Galluzzi L., et al. Cell death modalities: Classification and pathophysiological implications. Cell Death Differ 2007, 14(7):1237-1243.
14. Eisenberg-Lerner A., Bialik S., Simon H.U., et al. Life and death partners: Apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009, 16(7):966-975.
15. Degterev A., Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008, 9(5):378-390.
16. Nicotera P., Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23(16):2757-2765.
17. Wu Y.T., Tan H.L., Huang Q., et al. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 2008, 4(4):457-466.
18. Yu L., Alva A., Su H., et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304(5676):1500-1502.
19. Chen S.Y., Chiu L.Y., Maa M.C., et al. zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy 2011, 7(2):217-228.
20. Boya P., Gonzalez-Polo R.A., Casares N., et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005, 25(3):1025-1040.
21. Glick D., Barth S., Macleod K.F. Autophagy: Cellular and molecular mechanisms. J Pathol 2010, 221(1):3-12.
22. Brech A., et al. Autophagy in tumour suppression and promotion. Mol Oncol 2009, 3(4):366-375.
23. Degenhardt K., Mathew R., Beaudoin B., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10(1):51-64.
24. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411(6835):342-348.
25. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis 2000, 21(3):485-495.
26. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
27. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell 2011, 144(5):646-674.
28. Sanchez Alvarado A. Planarian regeneration: Its end is its beginning. Cell 2006, 124(2):241-245.
29. Gurtner G.C., Werner S., Barrandon Y., et al. Wound repair and regeneration. Nature 2008, 453(7193):314-321.
30. Hwang J.S., Kobayashi C., Agata K., et al. Detection of apoptosis during planarian regeneration by the expression of apoptosis-related genes and TUNEL assay. Gene 2004, 333:15-25.
31. Galliot B Injury-induced asymmetric cell death as a driving force for head regeneration in Hydra. Dev Genes Evol 2013, 223(1-2):39-53.
32. Chera S., Ghila L., Dobretz K., et al. Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration. Dev Cell 2009, 17(2):279-289.
33. Galliot B., Chera S. The Hydra model: Disclosing an apoptosis-driven generator of Wnt-based regeneration. Trends Cell Biol 2010, 20(9):514-523.
34. Haynie J.L., Bryant P.J. The effects of X-rays on the proliferation dynamics of cells in the wing disc of Drosophila melanogaster. Dev Genes Evol 1977, 183:85-100.
35. Perez-Garijo A., Martin F.A., Morata G. Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 2004, 131(22):5591-5598.
36. Ryoo H.D., Gorenc T., Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 2004, 7(4):491-501.
37. Huh J.R., Guo M., Hay B.A. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr Biol 2004, 14(14):1262-1266.
38. Fan Y., Bergmann A. Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. Dev Cell 2008, 14(3):399-410.
39. Snow M.H., Tam P.P. Is compensatory growth a complicating factor in mouse teratology?. Nature 1979, 279(5713):555-557.
40. Schwabe R.F., Bradham C.A., Uehara T., et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003, 37(4):824-832.
41. Sakurai T., Maeda S., Chang L., et al. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 2006, 103(28):10544-10551.
42. Maeda S., Kamata H., Luo J.L., et al. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121(7):977-990.
43. Li F., Huang Q., Chen J., et al. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal 2010, 3(110):ra13.
44. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science 1997, 276(5309):60-66.
45. Mitchell C., Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008, 3(7):1167-1170.
46. Atsumi G., Tajima M., Hadano A., et al. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation. J Biol Chem 1998, 273(22):13870-13877.
47. Lauber K., Bohn E., Krober S.M., et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003, 113(6):717-730.
48. Zhao X., Wang D., Zhao Z., et al. Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells. J Biol Chem 2006, 281(39):29357-29368.
49. Liou J.Y., Ellent D.P., Lee S., et al. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 2007, 25(5):1096-1103.
50. Feher I., Gidali J. Prostaglandin E2 as stimulator of haemopoietic stem cell proliferation. Nature 1974, 247(442):550-551.
51. North T.E., Goessling W., Walkley C.R., et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447(7147):1007-1011.
52. Balcer-Kubiczek E.K. Apoptosis in radiation therapy: A double-edged sword. Exp Oncol 2012, 34(3):277-285.
53. Ward J.F. DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol 1988, 35:95-125.
54. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461(7267):1071-1078.
55. Chen J., Dassarath M., Yin Z., et al. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: A review of new avenues in its management. Radiat Oncol 2011, 6:128.
56. Zois C.E., Koukourakis M.I. Radiation-induced autophagy in normal and cancer cells: Towards novel cytoprotection and radio-sensitization policies?. Autophagy 2009, 5(4):442-450.
57. Brown J.M., Attardi L.D. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005, 5(3):231-237.
58. Dewey W.C., Ling C.C., Meyn R.E. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995, 33(4):781-796.
59. Meyn R.E., Stephens L.C., Ang K.K., et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993, 64(5):583-591.
60. Hendry J.H., West C.M. Apoptosis and mitotic cell death: Their relative contributions to normal-tissue and tumour radiation response. Int J Radiat Biol 1997, 71(6):709-719.
61. Rich T., Allen R.L., Wyllie A.H. Defying death after DNA damage. Nature 2000, 407(6805):777-783.
62. Kim J.J., Tannock I.F. Repopulation of cancer cells during therapy: An important cause of treatment failure. Nat Rev Cancer 2005, 5(7):516-525.
63. Withers H.R., Taylor J.M., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988, 27(2):131-146.
64. Trott K.R. Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 1990, 19(4):1071-1075.
65. Marks L.B., Dewhirst M. Accelerated repopulation: Friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy. Int J Radiat Oncol Biol Phys 1991, 21(5):1377-1383.
66. Maciejewski B., Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991, 21(3):163-170.
67. Hopewell J.W., Nyman J., Turesson I. Time factor for acute tissue reactions following fractionated irradiation: A balance between repopulation and enhanced radiosensitivity. Int J Radiat Biol 2003, 79(7):513-524.
68. Marcu L., Bezak E. Modelling of tumour repopulation after chemotherapy. Australas Phys Eng Sci Med 2010, 33(3):265-270.
69. Davis A.J., Tannock J.F. Repopulation of tumour cells between cycles of chemotherapy: A neglected factor. Lancet Oncol 2000, 1:86-93.
70. Davis A.J., et al. Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: Pilot study. Cytometry A 2003, 51(1):1-6.
71. Withers H.R., Maciejewski B., Taylor J.M., et al. Accelerated repopulation in head and neck cancer. Front Radiat Ther Oncol 1988, 22:105-110.
72. Withers H.R. Radiation biology and treatment options in radiation oncology. Cancer Res 1999, 59(suppl 7):1676s-1684s.
73. Peters L.J., Withers H.R. Applying radiobiological principles to combined modality treatment of head and neck cancer-The time factor. Int J Radiat Oncol Biol Phys 1997, 39(4):831-836.
74. Begg A.C., Hofland I., Kummermehr J. Tumour cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiological data in three murine tumours. Eur J Cancer 1991, 27(5):537-543.
75. Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol Relat Stud Phys Chem Med 1986, 49(2):357-380.
76. Huang Z., Mayr N.A., Gao M., et al. Onset time of tumor repopulation for cervical cancer: First evidence from clinical data. Int J Radiat Oncol Biol Phys 2012, 84(2):478-484.
77. Marcu L., van Doorn T., Olver I. Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Phys Med Biol 2004, 49(16):3767-3779.
78. Suwinski R., Taylor J.M., Withers H.R. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative radiation therapy. Int J Radiat Oncol Biol Phys 1998, 42(5):943-951.
79. Wang J.Z., Li X.A. Impact of tumor repopulation on radiotherapy planning. Int J Radiat Oncol Biol Phys 2005, 61(1):220-227.
80. Revesz L. Effect of tumour cells killed by x-rays upon the growth of admixed viable cells. Nature 1956, 178(4547):1391-1392.
81. Seelig K.J., Revesz L. Effect of lethally damaged tumour cells upon the growth of admixed viable cells in diffusion chambers. Br J Cancer 1960, 14:126-138.
82. Morgan J.E., Gross J.G., Pagel C.N., et al. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J Cell Biol 2002, 157(4):693-702.
83. Nguyen D.H., Oketch-Rabah H.A., Illa-Bochaca I., et al. Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 2011, 19(5):640-651.
84. Lowe S.W., Cepero E., Evan G. Intrinsic tumour suppression. Nature 2004, 432(7015):307-315.
85. Fiandalo M.V., Kyprianou N. Caspase control: Protagonists of cancer cell apoptosis. Exp Oncol 2012, 34(3):165-175.
86. Lavrik I.N., Golks A., Krammer P.H. Caspases: Pharmacological manipulation of cell death. J Clin Invest 2005, 115(10):2665-2672.
87. Huang Q., Li F., Liu X., et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011, 17(7):860-866.
88. Castellone M.D., et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310(5753):1504-1510.
89. Shao J., Jung C., Liu C., et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 2005, 280(28):26565-26572.
90. Goessling W., North T.E., Loewer S., et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009, 136(6):1136-1147.
91. Kim K.W., Hwang M., Moretti L., et al. Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 2008, 4(5):659-668.
92. Moretti L., Kim K.W., Jung D.K., et al. Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor. Mol Cancer Ther 2009, 8(5):1270-1279.
93. Segura I., Serrano A., De Buitrago G.G., et al. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. FASEB J 2002, 16(8):833-841.
94. Senft J., Helfer B., Frisch S.M. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res 2007, 67(24):11505-11509.
95. Allaj V., Guo C., Nie D. Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. Cell Biosci 2013, 3(1):8.
96. Gdynia G., Grund K., Eckert A., et al. Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol Cancer Res 2007, 5(12):1232-1240.
97. Nakopoulou L., Alexandrou P., Stefanaki K., et al. Immunohistochemical expression of caspase-3 as an adverse indicator of the clinical outcome in human breast cancer. Pathobiology 2001, 69(5):266-273.
98. Yang L., Cao Z., Yan H., et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: Implication for cancer specific therapy. Cancer Res 2003, 63(20):6815-6824.